← Back to Search

Text Messaging Support for Psychosis Transition Care

N/A
Recruiting
Led By Vicky Stergiopoulos, MD, MHSc
Research Sponsored by Centre for Addiction and Mental Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months and 2 years
Awards & highlights

Summary

This trial will test whether a text messaging intervention can help young people with psychosis navigate the transition from emergency services to early intervention services.

Who is the study for?
This trial is for young people who've been referred to the CAMH early psychosis intervention (EPI) program from emergency services due to suspected psychosis. Participants must be able to communicate in basic written English.Check my eligibility
What is being tested?
The study tests whether text messages can help youth with psychosis transition better from the emergency department to EPI services. It compares an active SMS intervention against a sham SMS, focusing on attendance and engagement.See study design
What are the potential side effects?
Since this trial involves sending and receiving text messages as an intervention, there are no direct medical side effects associated with typical drug or treatment trials.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months and 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Psychotic Disorders
Secondary outcome measures
Change in psychotic illness as measured by the Clinical Global Impression (CGI)
Health care costs
Service engagement - Service Engagement Scale (SES)
+8 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active SMS InterventionExperimental Treatment1 Intervention
Participants assigned to the experimental arm will receive the active SMS intervention. Participants in the active intervention group who consent to participate will be asked to complete a web-based survey. Based on survey findings, purposive sampling will be used to select a subsample of 12 to 20 participants for qualitative interviews.
Group II: Sham SMSPlacebo Group1 Intervention
Participants assigned to the sham comparator will receive the sham SMS intervention. They will not be re-contacted.

Find a Location

Who is running the clinical trial?

Centre for Addiction and Mental HealthLead Sponsor
359 Previous Clinical Trials
81,373 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,354 Previous Clinical Trials
26,460,333 Total Patients Enrolled
Institute for Clinical Evaluative SciencesOTHER
36 Previous Clinical Trials
2,508,913 Total Patients Enrolled

Media Library

Active SMS Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04298450 — N/A
First Episode Psychosis Research Study Groups: Active SMS Intervention, Sham SMS
First Episode Psychosis Clinical Trial 2023: Active SMS Intervention Highlights & Side Effects. Trial Name: NCT04298450 — N/A
Active SMS Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04298450 — N/A
~15 spots leftby Dec 2024